AdAlta Ltd (ASX:1AD) managing director Dr Tim Oldham tells Proactive the company’s rights offer has raised A$1.28 million before costs, with commitments in hand to achieve the balance of the A$3.15 million target. The proceeds will help fund the early return to the clinic for lead asset AD-214 as well as progress partnering discussions.
AdAlta secures A$1.28 million in rights offer to advance AD-214
